258 related articles for article (PubMed ID: 3697434)
1. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
Kumar A; Alcser K; Grunhaus L; Greden JF
Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
[TBL] [Abstract][Full Text] [Related]
2. The dexamethasone suppression test in patients with mood disorders.
Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
[TBL] [Abstract][Full Text] [Related]
3. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
Maes M; De Ruyter M; Suy E
Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
Carroll BJ; Feinberg M; Greden JF; Haskett RF; James NM; Steiner M; Tarika J
J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
[TBL] [Abstract][Full Text] [Related]
5. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
Philipp M; Maier W; Holsboer F
Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
[TBL] [Abstract][Full Text] [Related]
6. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
Matsunaga H; Sarai M
Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
[TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test in the clinical setting.
Evans DL; Burnett GB; Nemeroff CB
Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
[TBL] [Abstract][Full Text] [Related]
8. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
Miller KB; Nelson JC
Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
[TBL] [Abstract][Full Text] [Related]
9. Multisteroid analysis after DST in depressed patients--a controlled study.
Holsboer F; Philipp M; Steiger A; Gerken A
J Affect Disord; 1986; 10(3):241-9. PubMed ID: 2943779
[TBL] [Abstract][Full Text] [Related]
10. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
[TBL] [Abstract][Full Text] [Related]
11. Four definitions of endogenous depression and the dexamethasone suppression test.
Zimmerman M; Coryell W; Pfohl B; Stangl D
J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
[TBL] [Abstract][Full Text] [Related]
12. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
Maes M; Vandewoude M; Schotte C; Cosyns P
Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
[TBL] [Abstract][Full Text] [Related]
13. The dexamethasone suppression test in relation to symptomatology: preliminary findings controlling for serum dexamethasone concentrations.
Smith J; Carr V; Morris H; Gilliland J
Psychiatry Res; 1988 Aug; 25(2):123-33. PubMed ID: 3174902
[TBL] [Abstract][Full Text] [Related]
14. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
Addington D; Addington J
Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
[TBL] [Abstract][Full Text] [Related]
15. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
Maes M; Van Gastel A; Blockx P; Martin M; Cosyns P; Scharpé S; Desnyder R
J Affect Disord; 1995 Aug; 34(4):291-300. PubMed ID: 8550955
[TBL] [Abstract][Full Text] [Related]
16. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
Kasper S; Beckmann H
Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
Syvälahti E
Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone suppression test: use of two different dexamethasone doses.
Hwang S; Zander J; Garvey M
J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in the interpretation of dexamethasone suppression test results in children: a review and report.
Steingard R; Biederman J; Keenan K; Moore C
Biol Psychiatry; 1990 Aug; 28(3):193-202. PubMed ID: 2198952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
